dibutyryl-cyclic-gmp and Hypoxia

dibutyryl-cyclic-gmp has been researched along with Hypoxia* in 3 studies

Other Studies

3 other study(ies) available for dibutyryl-cyclic-gmp and Hypoxia

ArticleYear
Identification and characterization of a novel freezing inducible gene, li16, in the wood frog Rana sylvatica.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:8

    The wood frog Rana sylvatica survives for weeks during winter hibernation with up to 65% body water frozen as ice. Natural freeze tolerance includes both seasonal and freeze-induced molecular adaptations that control ice formation, deal with long-term ischemia, regulate cell volume changes, and protect macromolecules. This report identifies and characterizes a novel freeze-inducible gene, li16, that codes for a protein of 115 amino acids. Northern blot analysis showed that li16 transcript levels rose quickly during freezing to reach levels 3.7-fold higher than control values after 24 h; immunoblotting showed a parallel 2.4-fold rise in Li16 protein. Regulatory influences on gene expression were assessed. Nuclear runoff assays confirmed that freezing initiated an increase in the rate of li16 transcription, and analysis of signal transduction pathways via in vitro incubation of liver slices implicated a cGMP-mediated pathway in li16 expression. Gene and protein expression in liver was also strongly stimulated by anoxia exposure, whereas the gene was less responsive to dehydration stress. The strong response of li16 to both freezing and anoxia, and the rapid down-regulation of the gene when oxygen was reintroduced, suggest that the Li16 protein may play a role in ischemia resistance during freezing.

    Topics: Amphibian Proteins; Animals; Blotting, Northern; Blotting, Western; Dibutyryl Cyclic GMP; Dose-Response Relationship, Drug; Freezing; Gene Expression Regulation; Hypoxia; Intestinal Mucosa; Liver; Myocardium; Ranidae; RNA, Messenger; Temperature; Time Factors; Transcription, Genetic; Up-Regulation; Water Deprivation

2002
Mechanisms underlying chemoreceptor inhibition induced by atrial natriuretic peptide in rabbit carotid body.
    The Journal of physiology, 1993, Volume: 460

    1. Previous studies in our laboratory revealed the presence of atrial natriuretic peptide (ANP) in preneural chemosensory type I cells of the cat carotid body, and demonstrated that submicromolar concentrations of the peptide inhibited carotid sinus nerve (CSN) activity evoked by hypoxia. In the present study, we have evaluated the role of the cyclic nucleotide second messenger, cyclic GMP (cGMP), and the involvement of type I cells in rabbit chemosensory inhibition. 2. Submicromolar concentrations of the potent ANP analogue, APIII, greatly elevated both the content and release of cGMP from the carotid body. Denervation experiments confirmed earlier immunocytochemical studies which suggested that APIII-induced cGMP production occurs almost exclusively in type I cells; these experiments also indicate that both the sympathetic and sensory innervation to the carotid body exert a trophic influence on the metabolism of this second messenger. 3. Submicromolar concentrations of APIII inhibited the CSN activity evoked by hypoxia (79.8 +/- 3.2% (mean +/- S.E.M.) inhibition with 100 nM APIII) and nicotine (74.5 +/- 3.6% inhibition with 100 nM APIII), but did not affect basal CSN activity established in 100% O2-equilibrated superfusion solutions. 4. The biologically inactive analogue of ANP, C-ANP, failed to produce CSN inhibition; however, the inhibitory effects of APIII were mimicked by cell-permeant analogues of cGMP (dibutyryl-cGMP and 8-bromo-cGMP, 2 mM), which likewise did not alter basal CSN activity. Because we found that unmodified cGMP was an ineffective inhibitor of CSN activity, our data suggest that APIII inhibition is mediated intracellularly by cGMP produced within the type I cells. 5. APIII does not inhibit the CSN activity produced by 20 mM K+ (in zero Ca2+ media), which very probably results from direct depolarization of the sensory nerve terminals. 6. Catecholamine release from the carotid body evoked by hypoxia is likewise not altered by APIII (100 nM). 7. The data are consistent with the notion that APIII and analogues of cGMP alter the release of excitatory and/or inhibitory transmitters from chemosensory type I cells in the carotid body.

    Topics: Animals; Atrial Natriuretic Factor; Carotid Body; Chemoreceptor Cells; Cyclic GMP; Denervation; Depression, Chemical; Dibutyryl Cyclic GMP; Dose-Response Relationship, Drug; Hypoxia; Nicotine; Peptide Fragments; Potassium; Rabbits

1993
[Effect of cyclic nucleotides and hormones of homologous methylation in nuclear homogenates of rat bone marrow].
    Biokhimiia (Moscow, Russia), 1980, Volume: 45, Issue:6

    In vitro and in vivo studies showed that methylation of homologous DNA in nuclear homogenates of rat bone marrow is controlled by cyclic nucleotides and some hormones. The cyclic nucleotides and their dibutyryl analogs inhibited homologous methylation of DNA in the presence and absence of phosphodiesterase inhibitors. In the presence of Ca2+ the inhibiting effect of the nucleotides was more pronounced. Prostaglandins inhibited DNA methylation in a weaker degree while insulin and erythropoietin had a stronger effect in comparison with the nucleotides. Histamine stimulated DNA methylation, whereas acute hypoxic hypoxia caused a reduction in the rate of DNA methylation.

    Topics: Animals; Bone Marrow; Bucladesine; Calcium; Cell Nucleus; Cyclic AMP; Cyclic GMP; Dibutyryl Cyclic GMP; DNA; DNA (Cytosine-5-)-Methyltransferases; Erythropoietin; Hypoxia; Insulin; Kinetics; Methylation; Methyltransferases; Rats

1980